Bullet flag-united-kingdom flag-ireland

THIS WEBSITE IS INTENDED FOR HEALTHCARE PROFESSIONALS IN THE UK & IRELAND*

Welcome to Chiesi Medical

By searching, I confirm my query is unsolicited. This information is provided as a professional courtesy for general educational and informational purposes only. It is not intended to provide medical advice for a particular patient. The information is intended to assist you in forming your own conclusions and clinical decisions.

Search Medical Information

Contact us

Submit your medical enquiry

Submit your request directly to our medical team.

Submit request

Call us

Speak live with a member of our Chiesi Medical Information team on 0800 009 2329 (UK), 1800 817 459 (IE).

Report Adverse Event

Report to Chiesi Pharmacovigilance

In the event of a suspected adverse event or side effect with no associated medical information enquiry, please contact our pharmacovigilance team on:

For the UK: 0800 009 2329 (UK) or pv.uk@chiesi.com

For Ireland: 1800 817 459 (IE) or pv.uk@chiesi.com

Report to MHRA or HPRA

Adverse events should be reported.

For the UK (MHRA): http://www.mhra.gov.uk/yellowcard or search MHRA Yellow Card in the Google Play or Apple App store.

For Ireland (HPRA): https://www.hpra.ie.

Chiesi Limited is an international, family owned pharmaceutical company, committed to helping patients make their lives better and to this end, it continuously strives to innovate and improve its products, taking both clinical and sustainability into full consideration.

Examples of our ongoing projects towards a more sustainable future include:

  • Pledging to become carbon neutral by 2035, by offsetting all greenhouse gas emissions generated by Chiesi – well ahead of the UK national target of 2050
  • Committing €350 million over a five-year period to the development of low global warming potential innovations to treat respiratory diseases
  • Partnering with a Manchester based company, Dsposal, supported by Innovate UK, to investigate alternative sustainable solutions to the plastic components of inhalers
  • Installing new technology at our manufacturing sites that aim to capture and reuse leaked propellant, which will reduce the carbon footprint from the manufacturing process
  • Launch of a 12-month pilot recycling scheme in the Leicestershire area in January 2021 to enable inhaler users to safely and effectively recycle their empty or expired inhalers through the post

In recognition of our commitment to sustainability, Chiesi is proud to have been recognised as a certified B Corp®, a business that strives to meet the highest social, legal and environmental standards to balance purpose and profit. B Corp® organisations are legally required to consider the impact of their decisions on their patients, community, employees, suppliers and the environment.

Close

Product Reference Material

For a full list of Chiesi’s products, including access to Summary of Product Characteristics (SPC) and Patient Information Leaflet (PIL), please click here.